期刊文献+

分化型甲状腺癌^(131)I治疗前刺激性Tg动态变化与远处转移的关系 被引量:26

Relationship between Variation of Pre-ablation Stimulated Thyroglobulin and Distant Metastasis in Patients with Differentiated Thyroid Cancer
下载PDF
导出
摘要 目的探讨分化型甲状腺癌(DTC)131 I治疗前未服或停服甲状腺激素状态下测定的刺激性甲状腺球蛋白(s Tg)的动态变化及其与远处转移的关系。方法远处转移组(M1)38例和非远处转移组(M0)130例。动态监测131I治疗前s Tg及相应促甲状腺激素(TSH)值(首次记为Tg1、TSH1,末次记为Tg2、TSH2)。比较两组Tg1、Tg2、s Tg变化值(ΔTg)及s Tg随TSH变化比值(ΔTg/ΔTSH)有无差异。用ROC曲线及最佳诊断界值点(DCP)评估以上指标对远处转移的预测价值。结果 M1组Tg1和Tg2均显著高于M0组(P均<0.001),ROC曲线下面积分别为0.921和0.942,其中Tg2对远处转移预测准确性更高,达85.71%(DCP=24.30 ng/ml,灵敏度92.11%,特异度83.85%)。两组间ΔTg及ΔTg/ΔTSH差异均有统计学意义(P均<0.01);△Tg/△TSH对远处转移预测准确性及特异度均优于Tg2(分别为87.50%和86.92%)。结论131I治疗前动态监测s Tg有助于提高DTC远处转移预测的准确性和特异度,△Tg/△TSH所反映的s Tg随TSH变化比值可作为DTC远处转移有效的预测指标。 Objective To investigate the relationship between the dynamic variation of pre-ablation stimulated thyroglobulin( s Tg) and distant metastasis in patietns with differentiated thyroid cancer( DTC).Methods DTC patients after total or near total thyroidectomy were divided into two groups as M1 group( n =38) and M0 group( n = 130) according to the presence of distant metastases or not. Clinical data including preablation s Tg and the corresponding thyrotropin( TSH) values were dynamically measured. The pre-ablation s Tg and corresponding TSH collected at the first time were defined as Tg1 and TSH1,while as Tg2 and TSH2 at thelast time. χ2test was used to compare the variation tendency of s Tg between these two groups. Tg1,Tg2,preablation s Tg variation( ΔTg),and ΔTg / ΔTSH ratio between M0 and M1 were compared by Mann-Whitney ranksum test. The receiver operating characteristic( ROC) curves and diagnostic critical point( DCP) were employed to evaluate the predictive values of the above indicators. Results Both Tg1 and Tg2 of M1 were significantly higher than those of M0( the Mann-Whitney rank-sum test: Tg1 P〈0. 001,Tg2 P〈0. 001). The corresponding areas under the ROC curve( AUC) to differentiate the two groups were 0. 921 and 0. 942,respectively. The cut-off value of Tg2,which was more accurate in predicting distant metastasis,was 24. 3 ng / ml with a sensitivity of 92. 11% and a specificity of 83. 85%. Both ΔTg and ΔTg / ΔTSH between these two groups were significantly different( the Mann-Whitney rank-sum test: ΔTg P = 0. 002,ΔTg / ΔTSH P〈0. 001). ΔTg / ΔTSH worked better than Tg2 in predicting distant metastasis with both higher accuracy( 87. 50%) and higher specificity( 86. 92%). Conclusions Dynamically tracing pre-ablation s Tg may improve the accuracy and specificity of distant metastases prediction in DTC patients. ΔTg / ΔTSH,which means the ratio of s Tg variation to TSH variation,may be a useful diagnostic marker for predicting distant metastases in DTC.
出处 《中国医学科学院学报》 CAS CSCD 北大核心 2015年第3期315-319,共5页 Acta Academiae Medicinae Sinicae
基金 国家自然科学基金(30970850) 卫生部行业科研专项项目(201202012)~~
关键词 分化型甲状腺癌 甲状腺球蛋白 131I治疗 外科治疗 differentiated thyroid cancer thyroglobulin radioiodine therapy surgical therapy
  • 相关文献

参考文献20

  • 1National Cancer Institute. SEER Cancer Statistics Factsheets:Thyroid Cancer[R/OL].[2014-09-15].
  • 2Sampson E,Brierley JD,Le LW,et al. Clinical management and outcome of papillary and follicular(differentiated)thyroid cancer presenting with distant metastasis at diagnosis[J]. Cancer,2007,110(7):1451-1456.
  • 3Nixon IJ,Whitcher M,Palmer FL,et al. The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland[J]. Thyroid,2012,22(9):884-889.
  • 4Lee J,Soh EY. Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors[J]. Ann Surg,2010,251(1):114-119.
  • 5Tuttle RM,Leboeuf R. Follow up approaches in thyroid cancer:a risk adapted paradigm[J]. Endocrinol Metab Clin North Am,2008,37(2):419-435.
  • 6Mazzaferri EL,Robbins RJ,Spencer CA,et al. A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma[J]. J Clin Endocrinol Metab,2003,88(4):1433-1441.
  • 7Eustatia-Rutten CFA,Smit JWA,Romijn JA,et al. Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma,a structured meta-analysis[J]. Clin Endocrinol,2004,61(1):61-74.
  • 8Cooper DS,Doherty GM,Haugen BR,et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J]. Thyroid,2009,19(11):1167-1214.
  • 9González C,Aulinas A,Colom C,et al. Thyroglobulin as early prognostic marker to predict remission at 18-24 months in differentiated thyroid carcinoma[J]. Clin Endocrinol,2014,80(2):301-306.
  • 10Kim H,Kim SJ,Kim IJ,et al. Limited clinical value of periablative changes of serum markers in the prediction of biochemical remission in patients with papillary thyroid cancer[J]. Nucl Med Mol Imaging,2013,47(4):268-272.

二级参考文献14

  • 1ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量:10
  • 2American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer,Cooper DS,Doherty GM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer[J].Thyroid:Official Journal of the American Thyroid Association,2009.1167-1214.
  • 3Giovanella L. Highly sensitive thyroglobulin measurements in differentiated thyroid carcinoma management[J].Clinical Chemistry and Laboratory Medicine,2008.1067-1073.
  • 4Salvatori M,Raffaelli M,Castaldi P. Evaluation of the surgical completeness after total thyroidectomy for differentiated thyroid carcinoma[J].European Journal of Surgical Oncology,2007,(5):648-654.doi:10.1016/j.ejso.2007.02.034.
  • 5Makarewicz J,Adanczewski Z,Knapska-Kucharska M. Evaluation of the diagnostic value of the first thyroglobulin determination in detecting metastases after differentiated thyroid carcinoma surgery[J].Experimental and Clinical Endocrinology & Diabetes,2006,(9):485-489.doi:10.1055/s-2006-951778.
  • 6Sampson E,Brierley JD,Le LW. Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis[J].Cancer,2007.1451-1456.doi:10.1002/cncr.22956.
  • 7Suh I,Vriens MR,Guerrero MA. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthlecell neoplasms of the thyroid[J].American Journal of Surgery,2010.41-46.doi:10.1016/j.amjsurg.2009.08.030.
  • 8Phan HT,Jager PL,van der Wal JE. The follow-up of patients with differentiated thyroid cancer and undeteetable thyroglobulin (Tg) and Tg antibodies during ablation[J].European Journal of Endocrinology,2008.77-83.doi:10.1530/EJE-07-0399.
  • 9Tourniaire J,Bernard MH,Ayzac L. Serum thyroglobulin assay after total unilateral thyroid lobectomy for differentiated thyroid cancer[J].Presse Medicale,1990.1309-1312.
  • 10张桂芝,谭建,刘雪辉,孟召伟.131I治疗分化型甲状腺癌术后患者疗效影响因素研究[J].中华核医学杂志,2010(4):259-263. 被引量:44

共引文献731

同被引文献149

引证文献26

二级引证文献185

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部